ArticleNature medicine2023
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.
Barry A Borlaug et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
91 papers cite itlatest 60 shown
this paperpooled ittrialcites it